List of works by Lauren E Abrey

A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme

scientific article published on 22 September 2006

A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas

scientific article

A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas.

scientific article

A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma

scientific article

A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05).

scientific article published on 17 September 2008

A phase II study of extended low-dose temozolomide in recurrent malignant gliomas

scientific article

A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis

scientific article

A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

scientific article

A phase II trial of oral gimatecan for recurrent glioblastoma

scientific article

A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases

scientific article published on 7 November 2007

A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM).

scientific article published on 19 November 2008

AT-18SURVIVAL ANALYSIS OF PATIENTS WITH A PFS EVENT WHO DID NOT RECEIVE POST-PROGRESSION THERAPY IN AVAGLIO (BEVACIZUMAB [BEV] PLUS RADIOTHERAPY [RT] AND TEMOZOLOMIDE [TMZ] FOR NEWLY DIAGNOSED GLIOBLASTOMA [GBM])

Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches

scientific article

Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study

scientific article

BI-22CORRELATION OF MOLECULAR SUBTYPES WITH OVERALL SURVIVAL (OS) IN AVAGLIO, A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB (BEV) PLUS RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) FOR NEWLY DIAGNOSED GLIOBLASTOMA (GBM)

Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials

scientific article

Bcl-6 predicts improved prognosis in primary central nervous system lymphoma

scientific article published on 01 January 2008

Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma

scientific article published in February 2014

Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report

scientific article published on 25 October 2007

CNS Hodgkin lymphoma

scientific article

Capecitabine therapy of central nervous system metastases from breast cancer

scientific article

Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience.

scientific article published on October 2010

Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete follow-up

scientific article published in January 2005

Chemotherapy and the treatment of brain metastases

scientific article published on December 2006

Chemotherapy for brain metastases: breast, gynecologic and non-melanoma skin malignancies.

scientific article published on January 2007

Chemotherapy for primary central nervous system lymphoma

scientific article published on 15 November 2006

Clinical monograph: Clinical considerations for older patients with glioblastoma

scientific article published in January 2010

Cognitive functions in low-grade gliomas: disease and treatment effects.

scientific article published on 19 July 2006

Cognitive functions in primary CNS lymphoma after single or combined modality regimens

scientific article published on 19 October 2011

Cognitive functions in primary central nervous system lymphoma patients treated with chemotherapy and stem cell transplantation: preliminary findings.

scientific article published in August 2003

Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma

scientific article

Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study

scientific article

Delayed neurotoxicity in primary central nervous system lymphoma

scientific article

Diagnosis and management of primary intraocular lymphoma: an update

scientific article published on September 2007

Diagnosis and treatment of primary central nervous system lymphoma

scientific article

Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials.

scientific article

Glioblastoma in the elderly: the Memorial Sloan-Kettering Cancer Center Experience (1997-2007).

scientific article published in August 2009

HG-128BO25041 - A PHASE II OPEN-LABEL, RANDOMIZED, MULTI CENTRE COMPARATIVE STUDY OF BEVACIZUMAB BASED THERAPY IN PAEDIATRIC PATIENTS WITH NEWLY DIAGNOSED SUPRATENTORIAL, INFRATENTORIAL CEREBELLAR, OR PEDUNCULAR HIGH GRADE GLIOMA.

scientific article published on 30 May 2016

High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib

scientific article published in June 2005

High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma.

scientific article published in November 2003

High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up.

scientific article published on 8 March 2006

High-grade gliomas in patients with prior systemic malignancies.

scientific article published in June 2002

Identifying and addressing barriers to the delivery of optimal therapy for primary central nervous system lymphoma in the broader community

scientific article published on December 2006

Imaging neurotoxicity: is a picture worth a thousand words?

scientific article published in February 2005

Initial treatment patterns over time for anaplastic oligodendroglial tumors

scientific article

Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis

scientific article published in November 2003

International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors

scientific article

International study on low-grade primary central nervous system lymphoma

scientific article published in May 2006

Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma

scientific article published on 26 February 2015

Intracranial dural metastases

scientific article

Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma?

scientific article published on 01 June 2002

Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?

scientific article

LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphoma

scientific article

Late relapse in primary central nervous system lymphoma: clonal persistence

scientific article

Leptomeningeal metastases from leukemias and lymphomas

scientific article

Leukemic and lymphomatous meningitis: incidence, prognosis and treatment

scientific article

Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma

scientific article published in October 2006

Long-term survival in primary CNS lymphoma

scientific article published on 01 March 1998

Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation

scientific article published on 03 August 2019

Longitudinal cognitive follow-up in low grade gliomas.

scientific article

Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas.

scientific article published on 28 June 2011

Magnetic resonance spectroscopy imaging in radiotherapy planning for recurrent gliomaa)

scientific article published on 01 May 2011

Maintenance therapy for central nervous system lymphoma with rituximab

scientific article published on 01 September 2009

Methotrexate area under the curve as a prognostic factor in primary central nervous system lymphoma treated with immunochemoradiotherapy

scientific article published on 24 June 2011

Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.

scientific article published in November 2005

Multicenter Phase II Study of Temozolomide and Myeloablative Chemotherapy with Autologous Stem Cell Transplant for Newly Diagnosed Anaplastic Oligodendroglioma

scientific article published on 2 May 2017

Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer

scientific article published on 26 August 2015

Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma

scientific article published on 9 July 2012

Myelosuppression in patients benefiting from imatinib with hydroxyurea for recurrent malignant gliomas.

scientific article published on 27 June 2007

NI-36VALIDATION OF RANO CRITERIA: CONTRIBUTION OF T2/FLAIR ASSESSMENT IN PATIENTS WITH RECURRENT GLIOBLASTOMA TREATED WITH BEVACIZUMAB.

scientific article published in November 2014

NIMG-01. DIFFUSION MRI PHENOTYPES PREDICT OVERALL SURVIVAL BENEFIT FROM ANTI-VEGF MONOTHERAPY IN GLIOBLASTOMA AT FIRST OR SECOND RELAPSE

scientific article published on 6 November 2017

NIMG-53. POST-SURGICAL, RESIDUAL ENHANCING TUMOR VOLUME IS PROGNOSTIC FOR OVERALL SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA: EVIDENCE FROM 1,458 PATIENTS POOLED FROM INTERNATIONAL TRIALS, SINGLE INSTITUTION DATABASES, AND MULTICENTER CONSORTIUMS

NIMG-84. TUMOR LOCATION IS PROGNOSTIC FOR OVERALL SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA: EVIDENCE FROM 1,458 PATIENTS POOLED FROM INTERNATIONAL TRIALS, SINGLE INSTITUTION DATABASES, AND MULTICENTER CONSORTIUMS

Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab

scientific article

Neurological outcome of long-term glioblastoma survivors.

scientific article

Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium.

scientific article published on 17 June 2008

New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting

scientific article

Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment

scientific article published on 01 July 2004

Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial

scientific article published on 29 June 2015

Patterns of care in elderly glioblastoma patients

scientific article published in December 2008

Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma

scientific article

Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma

scientific article

Patterns of treatment in older adults with primary central nervous system lymphoma

scientific article published on 01 September 2007

Pertussis immunity and response to tetanus-reduced diphtheria-reduced pertussis vaccine (Tdap) after autologous peripheral blood stem cell transplantation

scientific article published on 25 September 2009

Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy

scientific article published on July 2004

Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma

scientific article published on 15 April 2020

Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma

scientific article published on 20 February 2007

Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02.

scientific article published on 7 October 2017

Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.

scientific article

Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.

scientific article published in August 2006

Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02

scientific article published on 01 January 2020

Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02.

scientific article

Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma.

scientific article published on 8 August 2014

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).

scientific article

Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma

scientific article published on 19 July 2019

Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma

scientific article published on 14 December 2012

Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02).

scientific article

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.

scientific article

Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.

scientific article published in August 2006

Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.

scientific article published on 28 June 2009

Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma.

scientific article published on 7 February 2018

Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo

scientific article published on 01 October 2018

Post-treatment T1 shortening in primary CNS lymphoma.

scientific article published on 17 October 2012

Primary CNS lymphoma in children and adolescents: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG).

scientific article

Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group

scientific article published in April 2005

Primary central nervous system lymphoma

scientific article published on 01 September 2004

Primary central nervous system lymphoma

scientific article published on 01 July 2007

Primary central nervous system lymphoma

scientific article published on 01 November 2007

Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model

scientific article

Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy.

scientific article

Primary dural lymphomas: a clinicopathologic study of treatment and outcome in eight patients

scientific article published on 01 June 2006

Primary dural lymphomas: a review

scientific article published on 15 November 2006

Prognosis and patterns of care in elderly patients with glioma

scientific article published in December 2009

Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials

scientific article published on 12 December 2013

Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas

scientific article published on 04 March 2008

Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy

scientific article published in November 2008

Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.

scientific article published in January 2005

Quantitative Imaging Biomarkers for Risk Stratification of Patients with Recurrent Glioblastoma Treated with Bevacizumab

scientific article published on 11 May 2017

R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma

scientific article

Racial differences in primary central nervous system lymphoma incidence and survival rates

scientific article

Radiologic progression of glioblastoma under therapy - an exploratory analysis of AVAglio

scientific article published in September 2017

Radiotherapy and temozolomide for anaplastic astrocytic gliomas.

scientific article

Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma

scientific article

Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older

scientific article

Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors

scientific article

Reply to T.J. Kruser et al.

scientific article published on 16 February 2016

Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.

scientific article

Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD).

scientific article

Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab ⬇️

scientific article published on November 17, 2010

Response assessment criteria for glioblastoma: practical adaptation and implementation in clinical trials of antiangiogenic therapy.

scientific article

Response of glioblastomas to EGFR kinase inhibitors

scientific article published in February 2006

Response to Weltman and Fleury Malheiros, re Lassman et al.

scientific article

Retinopathy in survivors of primary central nervous system lymphoma

scientific article published in December 2006

Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome

scientific article

Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas

scientific article published on 23 January 2009

Salvage temozolomide for prior temozolomide responders

scientific article

Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide

scientific article published in September 2004

Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma

scientific article published on 01 September 2007

Sarcoidosis of the cauda equina mimicking leptomeningeal malignancy

scientific article published on 01 September 1998

Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas

scientific article

Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma

scientific article

Strategies to advance translational research into brain barriers

scientific article published on January 2008

Study of radiolabeled indium-111 and yttrium-90 ibritumomab tiuxetan in primary central nervous system lymphoma

scientific article published on 01 December 2007

Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002.

scientific article published in June 2003

Surrogate markers predict angiogenic potential and survival in patients with glioblastoma multiforme

scientific article published in May 2009

Survey of treatment recommendations for anaplastic oligodendroglioma

scientific article

Survival in elderly glioblastoma patients treated with bevacizumab-based regimens in the United States

scientific article published on 06 February 2018

Synchronous presentation of systemic and brain non-Hodgkin lymphoma

scientific article published on 01 December 2008

Systemic high-dose intravenous methotrexate for central nervous system metastases

scientific article published on 01 July 2006

Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium

scientific article

The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab

scientific article published on 21 October 2015

The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma

scientific article

The utility of body FDG PET in staging primary central nervous system lymphoma

scientific article published on 20 February 2008

Therapeutic challenges in primary CNS lymphoma

scientific article published on June 2009

Treatment of brain metastases: a short review of current therapies and the emerging role of temozolomide.

scientific article

Treatment patterns and prognosis in patients with human immunodeficiency virus and primary central system lymphoma

scientific article published in September 2008

Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study.

scientific article

Treatment-related neurotoxicity

scientific article

Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis

scientific article published in December 2005

Unraveling molecular markers of biologic therapies in glioma.

scientific article published in May 2006

Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio

scientific article

Utility of brain FDG-PET in primary CNS lymphoma

scientific article published in November 2008

Validation of post-operative residual contrast enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma.

scientific article published on 5 April 2018

YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma

scientific article published on 09 March 2011

Paulina is supported by:

About Paulina

Help